{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:20:51Z","timestamp":1781191251531,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clindermatol.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T04:35:36Z","timestamp":1646368536000},"page":"374-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The genetics and diagnosis of pediatric neurocutaneous disorders: Neurofibromatosis and tuberous sclerosis complex"],"prefix":"10.1016","volume":"40","author":[{"given":"Starling","family":"Tolliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb I.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2022.02.010_bib0001","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1177\/0883073807307093","article-title":"Intrafamilial phenotypic variability in tuberous sclerosis complex","volume":"22","author":"Lyczkowski","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0002","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/08830738050200080101","article-title":"Embryology of the neural crest: its inductive role in the neurocutaneous syndromes","volume":"20","author":"Sarnat","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0003","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborn","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0004","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von recklinghausen neurofibromatosis: a clinical and population study in south-east Wales","volume":"111","author":"Huson","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/bjc.1991.216","article-title":"An estimate of the heritable fraction of childhood cancer","volume":"63","author":"Narod","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0006","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O'Callaghan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0007","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1542\/pir.2015-0118","article-title":"Neurocutaneous disorders in children","volume":"38","author":"Korf","year":"2017","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0008","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1212\/CON.0000000000000562","article-title":"Neurocutaneous disorders","volume":"24","author":"Rosser","year":"2018","journal-title":"Contin Lifelong Learn Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-015-0612-7","article-title":"Neurocutaneous disorders for the practicing neurologist: a focused review","volume":"16","author":"Figueiredo","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.31.10.761","article-title":"Phenotypic variation of tuberous sclerosis in a single extended kindred","volume":"31","author":"Smalley","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0012","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.26.11.704","article-title":"A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity","volume":"26","author":"Huson","year":"1989","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","article-title":"Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas","volume":"54","author":"Antinheimo","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0014","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/jnnp-2018-318538","article-title":"Schwannomatosis: a genetic and epidemiological study","volume":"89","author":"Evans","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0883073816666736","article-title":"Neurofibromatosis type 2: presentation, major complications, and management, with a focus on the pediatric age group","volume":"32","author":"Ardern-Holmes","year":"2017","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/329246a0","article-title":"Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22","volume":"329","author":"Rouleau","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-0004.2009.01249.x","article-title":"SMARCB1\/INI1 maternal germ line mosaicism in schwannomatosis","volume":"77","author":"Hulsebos","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12964-016-0128-z","article-title":"Feedback activation of neurofibromin terminates growth factor-induced Ras activation","volume":"14","author":"Hennig","year":"2016","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.semcdb.2016.06.002","article-title":"Contextual signaling in cancer","volume":"58","author":"Smithson","year":"2016","journal-title":"Semin Cell Devel Bio"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0020","doi-asserted-by":"crossref","first-page":"30265","DOI":"10.1074\/jbc.M312083200","article-title":"Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0021","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ajmg.a.61125","article-title":"First International Conference on RASopathies and Neurofibromatoses in Asia: identification and advances of new therapeutics","volume":"179","author":"Rauen","year":"2019","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ng.2855","article-title":"Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas","volume":"46","author":"Piotrowski","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0023","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1634\/theoncologist.2012-0162","article-title":"Clinical features of schwannomatosis: a retrospective analysis of 87 patients","volume":"17","author":"Merker","year":"2012","journal-title":"oncologist"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0024","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","article-title":"Further genotype \u2013 phenotype correlations in neurofibromatosis 2","volume":"77","author":"Selvanathan","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0033291798006916","article-title":"Suicidal behaviour: an epidemiological and genetic study","volume":"28","author":"Statham","year":"1998","journal-title":"Psychol Med"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0026","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11940-011-0142-9","article-title":"Therapeutics for childhood neurofibromatosis type 1 and type 2","volume":"13","author":"Ardern-Holmes","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0027","unstructured":"Friedman JM. Neurofibromatosis 1. Available at: https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK1109\/. Accessed 06\/05\/2020."},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0028","first-page":"195","article-title":"Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling","volume":"20","author":"Terzi","year":"2009","journal-title":"Genet Couns"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0029","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/molehr\/gah170","article-title":"Preimplantation genetic diagnosis for neurofibromatosis type 1","volume":"11","author":"Spits","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0474-9","article-title":"Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with multiple ligation-dependent probe amplification analysis","volume":"25","author":"Wu-Chou","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0031","first-page":"69","article-title":"A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals","volume":"55","author":"Bourn","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0032","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cge.12007","article-title":"Mutation type and position varies between mosaic and inherited NF2 and correlates with disease severity","volume":"83","author":"Evans","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0033","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1399-0004.2011.01816.x","article-title":"Genetic testing and screening of individuals at risk of NF2","volume":"82","author":"Evans","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.20393","article-title":"Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings","volume":"28","author":"Ahronowitz","year":"2007","journal-title":"Human Mutation"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41434-019-0080-9","article-title":"Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors","volume":"26","author":"Bai","year":"2019","journal-title":"Gene Ther"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0036","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/gim.2018.28","article-title":"Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0037","first-page":"62","article-title":"Neurofibromatosis type 1: review and update on emerging therapies","volume":"8","author":"Karaconji","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0038","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0039-1691830","article-title":"Trametinib induces neurofibroma shrinkage and enables surgery","volume":"50","author":"Vaassen","year":"2019","journal-title":"Neuropediatr"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0039","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13053-019-0110-z","article-title":"Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature","volume":"17","author":"Suarez-Kelly","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0040","first-page":"1","article-title":"Neurofibromatosis","volume":"6","year":"1987","journal-title":"Natl Inst Health Consens Dev Conf Consens Statement"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/humu.22669","article-title":"Neurofibromatois type 1 without neurofibromas: genotype-phenotype correlations in NF1","volume":"36","author":"Kehrer-Sawatzki","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0042","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0043","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying nf1 missense mutations affecting p.arg1809: genotype-phenotype correlation","volume":"26","author":"Rojnueangnit","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0044","first-page":"709","article-title":"Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere","volume":"51","author":"Northrup","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0045","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0046","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jmg.30.1.41","article-title":"Variability of expression in tuberous sclerosis","volume":"30","author":"Northrup","year":"1993","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0047","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/hmg\/3.suppl_1.1477","article-title":"The molecular genetics of tuberous sclerosis","volume":"3","author":"Sampson","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0048","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/geno.1995.1079","article-title":"Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues","volume":"27","author":"Xu","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0049","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0051","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jmg.26.1.28","article-title":"Genetic aspects of tuberous sclerosis in the west of Scotland","volume":"26","author":"Sampson","year":"1989","journal-title":"J Med Genet"},{"issue":"277","key":"10.1016\/j.clindermatol.2022.02.010_bib0052","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"80","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0053","doi-asserted-by":"crossref","first-page":"16142","DOI":"10.1074\/jbc.RA118.003525","article-title":"The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding","volume":"293","author":"Madigan","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0054","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1074\/jbc.M115.701870","article-title":"Structural basis of the interaction between tuberous sclerosis complex 1 (TSC1) and tre2-bub2-cdc16 domain family member 7 (TBC1D7)","volume":"291","author":"Qin","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0055","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0056","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0057","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.febslet.2011.02.001","article-title":"TSC1\/TSC2 signaling in the CNS","volume":"585","author":"Han","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0058","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu Rev Genom Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0059","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K","article-title":"Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis","volume":"14","author":"Niida","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/302381","article-title":"Comprehensive mutation analysis of TSC1 and TSC2\u2014and phenotypic correlations in 150 families with tuberous sclerosis","volume":"64","author":"Jones","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0061","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-0004.2011.01648.x","article-title":"Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds","volume":"81","author":"Wentink","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0062","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1086\/302412","article-title":"High rate of mosaicism in tuberous sclerosis complex","volume":"64","author":"Verhoef","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0063","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1086\/302322","article-title":"Germ-line mosaicism in tuberous sclerosis: how common?","volume":"64","author":"Rose","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307389901400610","article-title":"Tuberous sclerosis consensus conference: recommendations for diagnostic evaluation","volume":"14","author":"Roach","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0066","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/6.13.2265","article-title":"Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis","volume":"6","author":"Yates","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0067","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(87)90396-5","article-title":"Genetics of tuberous sclerosis","volume":"1","author":"Hall","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0068","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1136\/jmg.2003.014126","article-title":"Somatic mosaicism is rare in unaffected parents of patients with sporadic tuberous sclerosis","volume":"41","author":"Roberts","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0069","first-page":"374","article-title":"Tuberous sclerosis complex","volume":"71","author":"Kaneda","year":"2019","journal-title":"Brain Nerve"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0070","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0071","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gim.2015.148","article-title":"Clinical application of whole-exome sequencing across clinical indications","volume":"18","author":"Retterer","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0072","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"Collins","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0073","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12881-015-0155-4","article-title":"Targeted next generation sequencing reveals previously unidentified TSC1 and TSC2 mutations","volume":"16","author":"Nellist","year":"2015","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0074","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/archdischild-2013-304340","article-title":"What is next generation sequencing?","volume":"98","author":"Behjati","year":"2013","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11262-017-1502-7","article-title":"Next-generation AAV vectors for clinical use: an ever-accelerating race","volume":"53","author":"Weinmann","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0076","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.omtm.2019.08.003","article-title":"Long-term therapeutic efficacy of intravenous AAV-mediated hamartin replacement in mouse model of tuberous sclerosis type 1","volume":"15","author":"Prabhakar","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0077","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0078","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/qjmed\/hcy215","article-title":"The UK guidelines for management and surveillance of tuberous sclerosis complex","volume":"112","author":"Amin","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0079","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pd.464","article-title":"Evaluating the risk of tuberous sclerosis in cases with prenatal diagnosis of cardiac rhabdomyoma","volume":"22","author":"Gamzu","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/pd.1197","article-title":"Precise prenatal diagnosis of tuberous sclerosis by sequencing the TSC2 gene","volume":"25","author":"Milunsky","year":"2005","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0081","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pd.1650","article-title":"Preimplantation genetic diagnosis at 20 years","volume":"27","author":"Jardim","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0082","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2009.04.004","article-title":"Preimplantation genetic diagnosis: state of the art","volume":"145","author":"Basille","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0083","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199903043400905","article-title":"Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis","volume":"340","author":"Kwiatkowska","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TACG.S90262","article-title":"Genetics of tuberous sclerosis complex: implications for clinical practice","volume":"10","author":"Caban","year":"2017","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0883073807309250","article-title":"Clinical presentation and diagnosis of tuberous sclerosis complex in infancy","volume":"23","author":"Datta","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107908","article-title":"Modifying genetic epilepsies \u2013 results from studies on tuberous sclerosis complex","volume":"166","author":"Jozwiak","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0087","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40265-019-01171-4","article-title":"Pharmacological and therapeutic properties of cannabidiol for epilepsy","volume":"79","author":"Franco","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0088","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/2150135118822711","article-title":"Rapid involution of large cardiac rhabdomyomas with everolimus therapy","volume":"12","author":"Garg","year":"2021","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0089","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pdpdt.2019.08.009","article-title":"Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex","volume":"28","author":"Shi","year":"2019","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0090","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.ad.2018.02.041","article-title":"Fibrous cephalic plaque in tuberous sclerosis complex: treatment with 0.2% rapamycin","volume":"110","author":"Giacaman","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0091","doi-asserted-by":"crossref","unstructured":"Zureick AH, McFadden KA, Mody R, Koschmann C. Successful treatment of a TSC2-mutant glioblastoma with everolimus. BMJ Case Rep. 20191;12:e227734.","DOI":"10.1136\/bcr-2018-227734"},{"key":"10.1016\/j.clindermatol.2022.02.010_bib0092","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00330-019-06412-4","article-title":"Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study","volume":"30","author":"Kim","year":"2020","journal-title":"Eur Radiol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:15Z","timestamp":1760034015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X22000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0738081X22000256"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics and diagnosis of pediatric neurocutaneous disorders: Neurofibromatosis and tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}